Randomized trial on the effect of non-calcium-containing phosphate binder lanthanum carbonate and calcium carbonate on FGF23 in hemodialysis patients
Not Applicable
- Conditions
- Chronic kidney disease
- Registration Number
- JPRN-UMIN000006333
- Lead Sponsor
- Juntendo University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) Malignancy of any type at enrollment 2) History of hypersensitivity to any of the ingredients of Lanthanum carbonate or Calcium carbonate 3) Severe hepatic dysfunction 4) Active digestive ulcer, ulcerative colitis, Crohn's disease and constriction of intestine 5) Pregnant or possibly pregnant women 6) Women on lactation 7) Ineligible patients according to the investigator's judgment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change of serum FGF23 levels
- Secondary Outcome Measures
Name Time Method Serum phosphate level achievement rate as defined by the JSDT guideline Safety